Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

Psychopharmacology

Volumn 145, Issue 2, 1999, Pages 193-204

  Krystal, John H ^a,b,c   D'Souza, D Cyril ^a,b   Karper, Laurence P ^a,b   Bennett, Alexandre ^a,b,d   Abi Dargham, Anissa ^a,b,f   Abi Saab, Danielle ^b   Cassello, Karyn ^b   Bowers Jr , Malcolm B ^a,e   Vegso, Sally ^c   Heninger, George R ^a,c   Charney, Dennis S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Abraham Ribicoff Research Facilities   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e Grace Education Building ^*  (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Attention; Dissociation Addiction; Dopamine; Extrapyramidal symptom; Frontal cortex; Glutamate; Ketamine; Memory; N Methyl D asparate; Neuroleptic; Psychosis; Wisconsin Card Sorting Test

Indexed keywords

HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FRONTAL CORTEX; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RANDOMIZED CONTROLLED TRIAL; SEDATION; WORKING MEMORY;

ADULT; ANESTHETICS, DISSOCIATIVE; ANTIPSYCHOTIC AGENTS; COGNITION; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HALOPERIDOL; HUMANS; HYDROCORTISONE; KETAMINE; MALE; PROLACTIN; RECEPTORS, N-METHYL-D-ASPARTATE; SLEEP STAGES;

EID: 0032809337     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051049     Document Type: Article

References (86)

1. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
2. Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135:1081-1084
3. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd Edn., Revised. American Psychiatric Association, Washington D.C.
4. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively decrease excitation of central neurons by N-methyl-D-aspartate. Br J Pharmacol 83:179-185
5. 1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116:43-151
6. 2 receptor mechanisms contribute to age-related cognitive decline: The effects of quinpirole on memory and motor performance in monkeys. J Neurosci 15:3429-3439
7. Bacopoulos NG, Redmond DE, Roth RH (1979) Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: Effects of ketamine and fluphenazine. J Neurochem 32:1215-1218
8. Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676
9. Becsey L, Malamed S, Radnay P, Foldes FF (1972) Reduction of the psychotomimetic and circulatory side effects of ketamine by droperidol. Anesthesiology 37:536-542
10. Bell MD, Billington RJ, Becker BR (1985) A scale for the assessment of reality testing: Reliability, validity and factorial invariance. J Clin Psychol 53:506-511
11. Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53-60
12. Berlant JL (1985) Reserpine and phencyclidine-associated psychosis: Three case reports. J Clin Psychiatry 46:542-544
13. Borkowski JG, Benton AL, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5:135-140
14. Bovill JG, Clarke RSJ, Dundee JW, Pandit SK, Moore J (1971) Clinical studies of induction agents. XXXVIII: Effects of premedicants and supplements on ketamine anesthesia. Br J Anesth 43:600-607
15. Bowers MB, Heninger GR, Sternberg D, Meitzer HY (1980) Clinical proceses and central dopaminergic activity in psychotic disorders. Commun Psychopharmacol 4:177-188
16. Bremner JD, Krystal JH, Putnam FW, Southwick SW, Marmar C, Charney DS, Mazure CM (1998) Measurement of dissociative states with the Clinician Administered Dissociative States Scale (CADSS) J Trauma Stress 11:125-136
17. Bresink I, Danysz W, Parson CG, Mutschler E (1995) Different binding affinities of NMDA receptor channel blockers in various brain regions-indication of NMDA receptor heterogeneity. Neuropharmacology 34:533-540
18. Byrd LD (1987) Effects of phencyclidine and ketamine on cardiovascular activity and temperature in the squirrel monkey. Life Sci 41:7-13
19. Carlezon WA Jr, Wise RA (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112-4222
20. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trend Neurosci 13:272-276
21. Castellani S, Adams PM, Giannini AJ (1982a) Physostigimine treatment of acute phencyclidine intoxication. J Clin Psychiatry 43:10-11
22. Castellani S, Giannini AJ, Adams PM (1982b) Physostigmine and haloperidol treatment of acute phencyclidine intoxication. Am J Psychiatry 139:508-510
23. Chapman LJ, Chapman JP, Miller EN (1982) Reliabilities and intercorrelations of eight measures of proneness to psychosis. J Consult Clin Psychol 50:187-195
24. Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety, II: Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14-24
25. Chouinard G, Ross-Chouinard A, Annabel L, Jones BD (1980) The extrapyramidal symptom rating scale [abstract]. Can J Neurol Sci 7:233
26. Domino EF, Chodoff P, Corssen G (1965) Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther 6:279-291
27. Ebguth PH, Reiman B, Klein RL (1972) The influence of chlorpromazine, diazepam, and droperidol on emergence from ketamine. Anesthesia Analg 51:693-700
28. Fauman MA, Fauman BJ (1978) The psychiatric aspects of chronic phencyclidine use: A study of chronic PCP users. NIDA Res Monogr 21:183-200
29. Geist ET, Gross BD (1982) Reduction of ketamine-induced emergence phenomena by preoperative promethazine. J Oral Maxillofac Surg 40:549-550
30. Goldstein K (1949) Frontal lobotomy and impairment of abstract attitude. J Nerv Ment Dis 110:93-111
31. Gordon M (1983) The Gordon Diagnostic System. Gordon Systems, DeWitt, N.Y.
32. Gorham DR (1956) A proverbs test for clinical and experimental use. Psychol Rep 2:1-12
33. 3H-phencyclidine in brain membranes. Life Sci 30:2147-2154
34. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigmal-binding site. Proc Natl Acad Sci USA 93:8072-8077
35. Hedlund JL, Vieweg BW (1980) The Brief Psychiatric Rating Scale (BPRS): A comprehensive review. J Operational Psychiatry 11:48-64
36. Helrich M, Atwood JM (1964) Modification of sernyl anesthesia with haloperidol. Anesthesia Analg 43:471-474
37. Irifune M, Shimizu T, Nomoto M (1991) Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav 40:399-407
38. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
39. Kamm GD, Bewes PC (1978) Ketamine anesthesia by continuous intravenous drip. Top Doct 8:68-72
40. Kane J, Honigfeld G, Singer J, Meltzer H, the Clozapine Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796
41. Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T (1994) Effects of risperidone on phencyclidine-induced behaviors: Comparison with haloperidol and ritanserin. Jpn J Pharmacol 66:181-189
42. Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969-974
43. Kretschmer BD, Zadow B, Volz TL, Schmidt WJ (1992). The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior. J Neural Transm Gen Sect 87:23-35
44. Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrissey KA, Abi-Saab D, Bremner JD, Bowers MB Jr, Suckow RF, Stetson P, Heninger GR, Charney DS (1998a) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology 135:213-229
45. Krystal LH, Petrakis I, Webb E, Cooney NL, Karper LP, Namanworth S, Trevisan LA, Stetson P, Charney DS (1998b) Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 55:354-360
46. Krystal JH, Abi-Dargham A, Laruelle M, Moghaddam B (1998c) Pharmacologic model psychoses. In: Charney DS, Nestler E, Bunney BS (eds) Neuroscience Basis of Psychiatry (in press)
47. Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS (1993) m-Chlorophenylpiperazine (MCPP) effects in neuroleptic-free schizophrenic patients: Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Arch Gen Psychiatry 50:624-635
48. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, congnitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
49. Krystal J, Karper L, D'Souza C, Webb E, Bennett A, Abi-Dargham A, Petrakis II, Brenner L, Morrissey K, Abi-Saab D, Charney D (1995) Differentiating NMDA dysregulation in schizophrenia and alcoholism using ketamine. Schizophr Res 15:156
50. Kucera H, Francis WN (1967) Computational Analysis of Present Day American English. Brown University Press, Providence, R.I.
51. Kuhar MJ, Boja JW, Cone EJ (1990) Phencyclidine binding to striatal cocaine receptors. Neuropharmacology 29:295-97
52. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19
53. 3H]hydroxy-N,N-di-n-propyl-a2-aminotetralin. Proc Natl Acad Sci USA 89:8155-8159
54. Lilburn JK, Dundee JW, Nair SG, Fee JP, Johnston HM (1978) Ketamine sequelae. Evaluation of the ability of various premedicants to attenuate its psychic actions. Anesthesiology 33:307-311
55. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug - Sernyl. AMA Arch Neurol Psychiatry 81:363-369
56. Luisada PV, Brown BI (1976) Clinical management of the phencyclidine psychosis. Clin Toxicol 9:539-545
57. Lynch DR, Gallagher MJ (1996) Inhibition of N-methyl-d-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors. J Pharmacol Exp Ther 279:154-161
58. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: The effects of ketamine in healthy subjects. Neuropsychopharmacology 14:301-308
59. Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A (1997) Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine. Biol Psychiatry 42:664-668
60. Milner B (1964) Some effects of frontal lobectomy in man. In: Warren JM, Akert K (eds) The Frontal Granular Cortex and Behavior. McGraw-Hill, New York, pp 313-334
61. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927
62. 2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol: Psychopharmacology 106:433-438
63. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799-812
64. Øye I, Hustveit O, Moberg ER, Pausen O, Skoglund LA (1991) The chiral forms of ketamine as probes for NMDA receptor function in humans. In: Kameyama T, Nabeshima T, Domino EF (eds) NMDA Receptor Related Agents: Biochemistry, Pharmacology and Behavior. NPP Books, Ann Arbor, Mich., pp 381-389
65. Øye N, Paulsen O, Maurset A (1992) Effects of ketamine on sensory preception: Evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209-1213
66. Rainey JM Jr, Crowder MK (1975) Prolonged psychosis attributed to phencyclidine: Report of three cases. Am J Psychiatry 132:1076-1078
67. Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL (1989) Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci 45:1065-1072
68. Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299-302
69. Sadove MS, Hatano S, Zahed B, Redlin T, Arastounejad P, Roman C (1971a) Clinical study of droperidol in the prevention of the side effects of ketamine anesthesia: A preliminary report. Anesthes Analg 50:388-393
70. Sadove MS, Hatano S, Thomason R, Redlin T, Arastounejad P, Roman V (1971b) Clinical study of droperidol in the prevention of the side effects of ketamine anesthesia: A progress report. Anesthes Analg 50:526-532
71. Salmaso D, Denes G (1982) Role of the frontal lobes on an attention task: A signal detection analysis. Percept Motor Skills 54:1147-1150
72. Siegel RK (1978) Phencyclidine and ketamine intoxication: A study of four populations of recreational users. In: Petersen RC, Stillman RC (eds) Phencyclidine (PCP) Abuse: An Appraisal. NIDA Research Monograph, Rockville, Md., 21:119-147
73. Slosson RL (1963) Slosson Intelligence Test (SIT) for Children and Adults. Slosson Educational Publications, East Aurore, NY.
74. Smith DE, Wesson DR, Buxton ME, Seymour R, Kramer HM (1978) The diagnosis and treatment of the PCP abuse syndrome. In: Petersen RC, Stillman RC (eds) Phencyclidine (PCP) Abuse: An Appraisal NIDA Monographs, US Government Printing Office, Rockville, Md., 21:229-240
75. Snell LD, Mueller ZL, Gannon RL, Silverman PB, Johnson KM (1984) A comparison between classes of drugs having phencylidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. J Pharmacol Exp Ther 231:261-269
76. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structural Clinical Interview for DSM-III-R-non-patient Edition (SCID-NP, Version 1.0). American Psychiatric Press, Washington, D.C.
77. Sturgeon RD, Fessler RG, London SF, Meltzer HY (1981) A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat. Eur J Pharmacol 76:37-53
78. Thiemann S, Csernansky JG, Berger PA (1987) Rating scales in research: The case of negative symptoms. Psychiatry Res 20:47-55
79. Verma A, Moghaddam B (1996) NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. J Neurosci 16:373-379
80. Wagner EJ, Moore KE, Lookingland KJ (1993) Sexual differences in N-methyl-D-aspartate receptor-mediated regulation of tuberoinfundibular dopaminergic neurons in the rat. Brain Res 611:139-146
81. Whittemore ER, IIyin VI, Woodward RM (1997) Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: Potency, subtype-selectivity and mechanism of inhibition. J Pharmacol Exp Ther 282:326-338
82. Wilkins AJ, Shallice T, McCarthy R (1987) Frontal lesions and sustained attention. Neuropsychologia 25:359-365
83. Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology by NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428
84. Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572-575
85. Yamakura T, Mori H, Masaki H, Shimoji K, Mishina M (1993) Differential sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. Neuroreport 4:687-690
86. Zeilhofer HU, Swandulla D, Geisslinger G, Brune K (1992) Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol 213:155-158